140 related articles for article (PubMed ID: 10720134)
1. CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3.
Zhou M; Gu L; Holden J; Yeager AM; Findley HW
Leukemia; 2000 Mar; 14(3):403-11. PubMed ID: 10720134
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of proliferative responses of human B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells to interleukin 7 (IL-7): no correlation with immunoglobulin gene status and expression of IL-7 receptor or IL-2/IL-4/IL-7 receptor common gamma chain genes.
Smiers FJ; van Paassen M; Pouwels K; Beishuizen A; Hählen K; Löwenberg B; Touw IP
Leukemia; 1995 Jun; 9(6):1039-45. PubMed ID: 7596167
[TBL] [Abstract][Full Text] [Related]
4. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
Petrucci MT; De Felice L; Ricciardi MR; Ariola C; Mascolo MG; Fenu S; Tafuri A
Cytokines Mol Ther; 1996 Dec; 2(4):225-30. PubMed ID: 9384708
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor enhances interleukin-3 dependent induction of 68-kD calmodulin-binding protein and thymidine kinase activity in NFS-60 cells.
Reddy GP; Quesenberry PJ
Blood; 1996 Apr; 87(8):3195-202. PubMed ID: 8605334
[TBL] [Abstract][Full Text] [Related]
8. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells.
Tomeczkowski J; Frick D; Schwinzer B; Wittner N; Ludwig WD; Reiter A; Welte K; Sykora KW
Leukemia; 1998 Aug; 12(8):1221-9. PubMed ID: 9697876
[TBL] [Abstract][Full Text] [Related]
10. Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
Juarez J; Baraz R; Gaundar S; Bradstock K; Bendall L
Haematologica; 2007 Apr; 92(4):450-9. PubMed ID: 17488655
[TBL] [Abstract][Full Text] [Related]
11. CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts.
Aldinucci D; Poletto D; Nanni P; Degan M; Rupolo M; Pinto A; Gattei V
Exp Hematol; 2002 Nov; 30(11):1283-92. PubMed ID: 12423681
[TBL] [Abstract][Full Text] [Related]
12. Cytokine receptor repertoire and cytokine responsiveness of Ho(dull)/Rh(dull) stem cells with differing potentials for G1/S phase progression.
Reddy GP; McAuliffe CI; Pang L; Quesenberry PJ; Bertoncello I
Exp Hematol; 2002 Jul; 30(7):792-800. PubMed ID: 12135678
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.
Trentin L; Zambello R; Agostini C; Enthammer C; Cerutti A; Adami F; Zamboni S; Semenzato G
Blood; 1994 Dec; 84(12):4249-56. PubMed ID: 7994039
[TBL] [Abstract][Full Text] [Related]
14. C-kit receptors in childhood malignant lymphoblastic cells.
Sykora KW; Tomeczkowski J; Reiter A
Leuk Lymphoma; 1997 Apr; 25(3-4):201-16. PubMed ID: 9168431
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
[TBL] [Abstract][Full Text] [Related]
17. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukins 1, 3, 6, stem cell factor and their receptors in acute leukemia blast cells and in normal peripheral lymphocytes and monocytes.
Ferrari S; Grande A; Manfredini R; Tagliafico E; Zucchini P; Torelli G; Torelli U
Eur J Haematol; 1993 Mar; 50(3):141-8. PubMed ID: 7682516
[TBL] [Abstract][Full Text] [Related]
19. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
[TBL] [Abstract][Full Text] [Related]
20. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
